Novation Signs a Spinal Implant Agreement
Over the past several years, the spinal market has been one of the most attractive segments in orthopedics because of its high growth rates and relative lack of price pressure. But the recent signing of an agreement between spinal market leader Medtronic Sofamor Danek and Novation Inc. suggests the spinal market's high-flying days may be over.
You may also be interested in...
Phase I data presented at ASCO for ALLO-501 offer proof of concept for the CD19 allogeneic CAR-T and a companion drug, ALLO-647, for lymphodepletion.
Dispatches from a world turned upside down covering a possible US government investigation into BARDA contracting practices and Medicare Part D plans waiving cost sharing for COVID-19 treatments.
The US FDA requests several manufacturers recall extended-release metformin based on studies confirming a higher NDMA impurity threshhold; previous testing found no significant risks.